Open Stent Solution

Based in Dury, France, and founded in 2018, Open Stent Solution operates as a medical technology company that develops open-stent heart valves, a modification in transcatheter mitral valve replacement. The company was founded by its CEO Doctor Doron Carmi, a senior cardiac surgeon, and is backed by investors led by Angels Santé in a EUR 2. 5 million Seed funding in September 2021. Open Stent Solution developed an open-stent heart valve and the only device which enables the implant of large-size mitral valves through small delivery systems, comparable in size to transcatheter aortic valve implantation.

The valve components are attached to a ribbon-shaped open stent, which reduces the overall device's size when loaded onto a delivery system. The heart valve gets locked once implanted, and form a circular shape with stable radial anchoring force exactly like balloon-expandable devices. Open Stent Solution plans to further develop its ribbon-shaped stented mitral valve for transcatheter replacement and offer more transfemoral solutions to millions of patients with failed mitral valves who cannot access treatment today.